This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Hemoglobin A1c Monitoring Industry

QuoTest Eyes the US Market III-3

QuoLab - A Cost Effective HbA1c Solution for Developing

Markets III-3

Competitive Landscape III-4

US Near Patient HbA1c Testing - A Highly Consolidated Market III-4

Diabetes in the US III-5

Highlights III-5

The Statistics III-6

Age Factor III-6

Table 10: US Diabetes Statistics (2010): Number of

Diabetics and % Prevalence by Age Group -20 -39 Years,

45-59 Years, and 60 - 79 Years (includes corresponding

Graph/Chart) III-6

Diabetes Risk Among Young Native Americans III-6

Mean HbA1c Scores at National Level III-7

Prevalence by Race/Ethnicity III-7

Table 11: US Market for Diabetes (2010): Percentage

Breakdown of Prevalence by Race/Ethnicity- Non-Hispanic

Blacks and Non-Hispanic Whites (includes corresponding

Graph/Chart) III-7

North American Diabetic Prevalence Data III-8

Table 12: North American and Caribbean Regional Population

and Diabetes Prevalence Statistics (2010 Estimates) - Top

Regions with High Prevalence of Diabetes for Various Age

Groups (20-39, 40-59, and 60-79) and Gender (Male and

Female) (includes corresponding Graph/Chart) III-8

Table 13: North American and Caribbean Diabetes and

Population Statistics (2010 & 2030) III-9

Product Approvals/Launches III-9

Strategic Corporate Developments III-11

Select Key Players III-13

B.Market Analytics III-17

Table 14: US Recent Past, Current and Future Analysis for

HbA1c Monitoring by Test Type - Laboratory Testing and Point

of Care Testing Markets Independently Analyzed with Annual

Sales Figures in US$ Million or Years 2010 through 2018

(includes corresponding Graph/Chart) III-17

Table 15: US Historic Review for HbA1c Monitoring by Test

Type - Laboratory Testing and Point of Care Testing Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-18

Table 16: US 15-Year Perspective for HbA1c Monitoring by

Test Type - Percentage Breakdown of Dollar Sales for

Laboratory Testing and Point of Care Testing Markets for

years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) III-19

6 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs